Free Trial
→ Big Oil’s big pivot (From Stansberry Research) (Ad) Buy ABBV Stock  Free ABBV Stock Alerts

AbbVie (ABBV) Short Interest Ratio & Short Volume

AbbVie logo
$185.52 +2.26 (+1.23%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$185.64 +0.13 (+0.07%)
As of 06:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

AbbVie Short Interest Data

AbbVie (ABBV) has a short interest of 19.80 million shares. This marks a 17.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 6.23 million shares to cover all short positions.

Current Short Interest
19,800,000 shares
Previous Short Interest
16,840,000 shares
Change Vs. Previous Month
+17.58%
Dollar Volume Sold Short
$3.86 billion
Short Interest Ratio
2.6 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
1,766,403,000 shares
Percentage of Shares Shorted
1.12%
Today's Trading Volume
5,720,849 shares
Average Trading Volume
6,227,300 shares
Today's Volume Vs. Average
92%
Short Selling AbbVie?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

AbbVie Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202519,800,000 shares $3.86 billion +17.6%N/A2.6 $195.15
4/15/202516,840,000 shares $2.98 billion -1.8%1.0%2.3 $176.84
3/31/202517,140,000 shares $3.60 billion -13.0%1.0%2.4 $209.83
3/15/202519,700,000 shares $4.17 billion +6.4%1.1%3.1 $211.90
2/28/202518,510,000 shares $3.87 billion -5.7%1.1%3 $209.07
2/15/202519,620,000 shares $3.79 billion +3.7%1.1%3.3 $193.00
1/31/202518,930,000 shares $3.48 billion +4.2%1.1%2.9 $183.90
1/15/202518,160,000 shares $3.11 billion +6.8%N/A2.8 $171.32
12/31/202417,000,000 shares $3.02 billion -8.3%N/A2.7 $177.70
12/15/202418,530,000 shares $3.21 billion -4.1%N/A3 $173.37
11/30/202419,320,000 shares $3.53 billion -4.2%N/A3.3 $182.93
11/15/202420,170,000 shares $3.33 billion +11.3%N/A3.5 $164.91
10/31/202418,130,000 shares $3.70 billion +12.1%N/A3.7 $203.87
10/15/202416,180,000 shares $3.10 billion +8.9%0.9%3.4 $191.86
9/30/202414,860,000 shares $2.93 billion -16.5%0.8%3.2 $197.48
9/15/202417,790,000 shares $3.45 billion -8.7%1.0%3.5 $194.21
8/31/202419,490,000 shares $3.83 billion -3.5%1.1%3.7 $196.31
8/15/202420,190,000 shares $3.90 billion +15.2%1.2%3.7 $193.40
7/31/202417,530,000 shares $3.25 billion +7.0%1.0%3.2 $185.32
7/15/202416,380,000 shares $2.75 billion +1.0%0.9%3 $168.03
6/30/202416,220,000 shares $2.78 billion +6.4%0.9%3 $171.52
6/15/202415,250,000 shares $2.57 billion -7.5%0.9%2.9 $168.59
5/31/202416,490,000 shares $2.66 billion +3.5%0.9%2.9 $161.19
5/15/202415,930,000 shares $2.61 billion +10.0%0.9%2.9 $163.78
4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69
4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67
3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10
3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88
2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61
2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61
1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36
1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40
12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97
12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07
11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35
11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61
10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18
10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96
9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06
9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09
Trump Quietly Planning $15 Trillion Crypto Shocker (Ad)

Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.

Watch the urgent crypto briefing while there’s still time
8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96
8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12
7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58
7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01
6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72
6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89
5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96
5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59
4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12
4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59
3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37
3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06
2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90
2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06
1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75
1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60
12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61
12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10
11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18
11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04
10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40
10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94
9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21
9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51
8/31/202211,380,000 shares $1.53 billion -12.5%N/A2.1 $134.46
8/15/202213,010,000 shares $1.85 billion -6.1%N/A2.2 $142.29
7/31/202213,850,000 shares $1.99 billion -1.3%0.8%2.2 $143.51
7/15/202214,030,000 shares $2.16 billion -2.7%0.8%2.1 $153.62
6/30/202214,420,000 shares $2.21 billion +6.7%1.0%2 $153.16
6/15/202213,520,000 shares $1.87 billion +6.0%0.9%1.9 $138.09
5/31/202212,750,000 shares $1.88 billion -10.4%0.7%1.8 $147.37
5/15/202214,230,000 shares $2.18 billion +8.2%0.8%1.9 $153.50
4/30/202213,150,000 shares $1.93 billion +9.0%0.8%1.7 $146.88
4/15/202212,070,000 shares $1.96 billion -10.2%0.7%1.5 $162.31
3/31/202213,440,000 shares $2.18 billion -9.7%0.8%1.7 $162.11
3/15/202214,890,000 shares $2.32 billion -6.9%N/A1.9 $155.88
2/28/202215,990,000 shares $2.36 billion +3.9%N/A2 $147.77
2/15/202215,390,000 shares $2.23 billion -4.7%N/A2 $144.76
1/31/202216,150,000 shares $2.21 billion +12.7%0.9%2.3 $136.89
1/15/202214,330,000 shares $1.95 billion -13.7%0.8%2.2 $135.87
12/31/202116,610,000 shares $2.25 billion +7.6%0.9%2.7 $135.40
12/15/202115,440,000 shares $2.01 billion +9.4%0.9%2.5 $130.23
11/30/202114,120,000 shares $1.63 billion +0.2%N/A2.3 $115.28
11/15/202114,090,000 shares $1.65 billion +3.5%0.8%2 $116.84
10/29/202113,620,000 shares $1.56 billion +18.5%0.8%1.9 $114.67
10/15/202111,490,000 shares $1.26 billion -16.0%0.7%1.6 $109.33
9/30/202113,670,000 shares $1.47 billion +5.2%0.8%1.9 $107.87
9/15/202112,990,000 shares $1.40 billion -4.1%0.7%1.9 $107.77
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
Trump Quietly Planning $15 Trillion Crypto Shocker (Ad)

Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.

Watch the urgent crypto briefing while there’s still time
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83
5/28/202114,760,000 shares $1.67 billion -3.4%0.8%2.1 $113.20
5/14/202115,280,000 shares $1.78 billion +2.6%N/A2.2 $116.60
4/30/202114,890,000 shares $1.65 billion -20.4%N/A2.2 $110.89
4/15/202118,710,000 shares $1.98 billion +11.4%N/A2.6 $105.90
3/31/202116,800,000 shares $1.79 billion +3.7%N/A2.3 $106.79
3/15/202116,200,000 shares $1.75 billion +5.0%N/A2.2 $108.22
2/26/202115,430,000 shares $1.66 billion +8.1%N/A2.2 $107.33
2/12/202114,280,000 shares $1.48 billion -4.0%N/A1.9 $103.75
1/29/202114,870,000 shares $1.55 billion +18.1%N/A1.9 $104.21
1/15/202112,590,000 shares $1.41 billion -5.6%N/A1.5 $111.63
12/31/202013,330,000 shares $1.40 billion -3.8%N/A1.6 $105.27
12/15/202013,850,000 shares $1.44 billion +4.4%N/A1.7 $104.20
11/30/202013,270,000 shares $1.39 billion -5.2%N/A1.6 $104.89
11/15/202014,000,000 shares $1.39 billion +9.0%N/A1.7 $99.04
10/30/202012,840,000 shares $1.04 billion +20.7%N/A1.6 $80.67
10/15/202010,640,000 shares $915.78 million -17.8%N/A1.5 $86.07
9/30/202012,940,000 shares $1.13 billion -2.6%N/A1.9 $87.59
9/15/202013,280,000 shares $1.21 billion +9.2%N/A1.9 $90.91
8/31/202012,160,000 shares $1.16 billion -2.0%N/A1.7 $95.77
8/14/202012,410,000 shares $1.18 billion -6.3%N/A1.7 $95.07
7/31/202013,240,000 shares $1.26 billion -3.2%N/A1.5 $94.91
7/15/202013,680,000 shares $1.37 billion -15.6%N/A1.4 $100.48
6/30/202016,210,000 shares $1.59 billion -18.0%N/A1.6 $98.18
6/15/202019,760,000 shares $1.84 billion +2.9%N/A1.8 $93.08
5/29/202019,200,000 shares $1.78 billion -22.6%N/A1.5 $92.67

ABBV Short Interest - Frequently Asked Questions

What is AbbVie's current short interest?

Short interest is the volume of AbbVie shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 19,800,000 shares of ABBV short. Learn More on AbbVie's current short interest.

What is a good short interest ratio for AbbVie?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 3.0. Learn More on AbbVie's short interest ratio.

Which institutional investors are shorting AbbVie?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Millennium Management LLC, Bosun Asset Management LLC, Cubist Systematic Strategies LLC, Royal Bank of Canada, Caption Management LLC, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Susquehanna International Group LLP, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, ADAPT Investment Managers SA, Capital Fund Management S.A., Garda Capital Partners LP, Sumitomo Mitsui Financial Group Inc., Maven Securities LTD, Marathon Trading Investment Management LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., XY Capital Ltd, Delta Accumulation LLC, Bank of Nova Scotia, Gladius Capital Management LP, LPL Financial LLC, Readystate Asset Management LP, Allianz Asset Management GmbH, Portman Square Capital LLP, SteelPeak Wealth LLC, Fulcrum Asset Management LLP, SG Americas Securities LLC, IMC Chicago LLC, CenterStar Asset Management LLC, Wealth Enhancement Advisory Services LLC, and NorthCrest Asset Manangement LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is AbbVie's short interest increasing or decreasing?

AbbVie saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 19,800,000 shares, an increase of 17.6% from the previous total of 16,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AbbVie's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbbVie: Eli Lilly and Company (0.86%), Johnson & Johnson (0.82%), Merck & Co., Inc. (1.48%), Pfizer Inc. (2.03%), Bristol-Myers Squibb (1.83%), Zoetis Inc. (2.10%), Royalty Pharma plc (5.42%), Corcept Therapeutics Incorporated (14.06%), Jazz Pharmaceuticals plc (9.09%), Perrigo Company plc (3.80%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short AbbVie stock?

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading up $2.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbbVie?

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

How often is AbbVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is April, 30 2025.



Related Companies
Short Interest Tools

This page (NYSE:ABBV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...
The Tomorrow Investor | Sponsored
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored